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NASA's initiatives to encourage the US private sector to invest in space hardware, products, and 
services are approximately 10 years old. These initiatives have worked and have encouraged the private 
sector to invest in commercial space projects. 1be Office of Advanced Concepts and Technology (formally 
NASA's Office of Commercial Programs) has over the years initiated several innovative programs to 
provide access to space for commercial entities having developed their own hardware with private sector 
resources. These innovative agreements range from direct "pay to fly" agreements to barter arrangements 
with a commercial entity. 
The purp:lse of this paper is to present an overview of the QJmmercial ,MDA ff A E.EJerimems 
(CMIX) Program, which has flown two Space Shuttle missions during the past 16 months. The paper will 
show typical data results of new biomedical applications that can be obtained from space processing 
operations that can be a benefit to the US. 
Figure 1 presents a comparison of microencapsulation of drug experiments conducted in space and 
on Earth. The unique space microcapsules clearly show an advantage because the microspheres are more 
uniform in size and sphericity, and have multilayers of alternating aqueous and non-aqueous fluids. They 
also have a tougher skin that allows manipulation and a long shelf life. Microcapsule of anti-tumor drugs, 
antibiotics, and enzymes that dissolve blood clots have been processed in space. Microencapsulation 
technology is used for drug delivery systems. 
Figure 2 shows an aldolase protein crystal grown in space, which is significantly larger than the 
same protein crystal grown on Earth. Data from several flights suggest that the rate of growth of some 
protein crystals can be accelerated in space. 
This is particularly imponant to IT A's space cancer research program. Figure 3 shows a small 50 
micron uroldnase protein crystal grown in space on our commercial. CMIX-2 Shuttle flight in April 1993. 
Urok::inase is an enzyme that is secreted when cancer metastasis occurs. Accordingly, if large enough 
protein crystals of urokinase can be grown to permit the structure to be determined, a drug could be 
designed to inhibit the spread of cenain cancers, especially breast cancer. Urokinase protein crystals have 
be.en grown in eight days using ITA's commercial automated laboratory on three separate Shuttle flights 
using two different techniques. The 50 micron urokinase protein crystal grown in space is too small to 
determine the strucrure, but appears to be repeatable for the flights. It takes approximately six months or 
more to grow the same size crystal on the ground. The structure of urokinase is not known due to the 
inability to grow the crystal large enough on the ground. Our space microgravity research leads us to 
l:elieve that the accelerated growth rate in space will produce larger crystals which are al.so better ordered 
and which will produce a better diffraction pattern. 
Effons are being made to grow large urokinase protein crystals for structural determination on the 
CMIX-3 flighc scheduled for I994. This cancer resean:h is being sponsored and funded by ITA wich che 
support from other organizations. We will be flying both a longer mission and will be trying a third crystal 
growth teclmique that promises to produce sufficiently larger crystals. 
The paper will al.so illustrate how biomedical applications from space processing can potentially 
benefit che nation. 
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SPECIMEN BLOCK CONTAINING 140 TEST SAMPLE WELLS 
. . . . . . . . . . 
. . 
. . . 
J 
PROTEIN CRYSTAL GROWN JN THE MOA 
APPLICATIONS: 
• BIOMEDICAL (prolein cryslal growlh) 
• FLUID SCIENCES (dillusion) MDA FLIGHT UNIT 
• MANUFACTURING (lhin mm membrane casling) 
e=:STRUMENTATION 
• TECHNOWGY 
~OCIATES.INC. MDA Principle of Block Operation 
Liquid 1 B ~11ockM;•11er:~~I 
Uqui<:I 2 Li~uid 1 Mixes Mixed Liquids 
with Liquid 2 Are Separated 
~INSTRUMENTATION 
- TECHNOLOGY ~OCIATES'.INC. 
The CMIX-1 & 2 Payloads flown on 
Space Shuttle Flights STS-52 & 56 
Utilized four ITA MDA Minilab Units 
~STRUME!ffATION 
• TECHNOlOGY 
~OCIATES.INC. 
MDA Flight Blocks Being Loaded During 
the Fluid Loading Rehearsal for STS-37 at 
KSC, Florida, March 3-8, 1991 
-Astronaut Ken Cockrell Activating the ITA MDA Minilabs 
of the CMIX-2 Payload on Space Shuttle Flight STS-56 
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Microencapsulation Experiment for Drug "Delivery 
This experiment was conducted by Dr. Dennis Morrison of NASA/JSC and Dr. Ben 
Mosier of the Institute for Research in Houston, Texas on IT A's MDA minilab flown 
on the Consort 4 sounding rocket flight. 
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Microgravity Encap ulation of Drug Experiments 
Conducted in Space Show l'illore 
Uniform Size and Sphericity 
EARTH SPACE 
• Earth experiments show random size and single-walled unilamellar microcapsules 
• Space experiments show uniform size and sphericity plus unique multi-lamellar microspheres 
• Space data obtained in ITA's automated laboratory-flown on Shuttle flight STS-56 on the CMIX-2 payload 
• Photos courtesy of Dr. Dennis Morrison and Dr. Benjamin Mosier 
Aldolase Protein Crystals Grown 
in IT A's Automated Laboratory Show that the Space 
Grown Crystals Tend to be Larger 
EARTH SPACE 
Pholos courtesy of Dr. Jurgen Sygusch, University of Mon1real 
Urokinase Protein Crystal Growth in Microgravity 
A Case Study in Cancer Remediation 
Blow-up of Urokinase Protein Crystal 
(50 micron crystal) 
• On Earth this protein crystal requires 6 or 
more months to grow 
• In Space this protein crystal was grown in 
ITA's Automated Laboratory In 8 days 
• Increased growth rate In Space (size) permits 
structure determination 
• Structure determination permits rational 
drug design 
Urokinase Protein Crystal 
(50 micron crystal) 
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